Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct;40(10):2569-2576.
doi: 10.1007/s10792-020-01437-x. Epub 2020 Jun 7.

The ocular manifestations in IBD screening (OMIS) questionnaire: pilot study on detection of ocular involvement in inflammatory bowel diseases

Maria Vadalà  1 , Chiara Davì  2 , Giuseppe Ingrassia Strano  3 , Enrica Giuffrida  3 , Barbara Scrivo  3 , Nicasio Ventura  2 , Massimo Castellucci  2 , Salvatore Cillino  2 , Calogero Cammà  3 , Maria Cappello  3
Affiliations

The ocular manifestations in IBD screening (OMIS) questionnaire: pilot study on detection of ocular involvement in inflammatory bowel diseases

Maria Vadalà et al. Int Ophthalmol. 2020 Oct.

Abstract

Purpose: To assess the usefulness of a dedicated questionnaire for patients with inflammatory bowel diseases (IBD) treated with biological drugs for the detection of ocular extraintestinal manifestations (EIMs). IBD can cause extraintestinal symptoms including ocular complaints which are frequently ignored and may be associated with significant morbidity, including blindness.

Methods: We developed a questionnaire, named Ocular Manifestations in IBD Screening (OMIS) questionnaire, after agreement between gastroenterologists and ophthalmologists. The questionnaire was administered by a non-ophthalmologist physician to 96 IBD patients treated with biological drugs.

Results: 35 patients (36.5%) were selected for the ophthalmologic examination on the basis of a positive screening test. Ocular EIMs were detected in 29 of 35 patients (83%).

Conclusion: A specific questionnaire can be useful for non-ophthalmologist physicians in a real world setting in order to select patients to be addressed to an ophthalmological visit, creating an integrated multidisciplinary clinical team, to improve management of IBD in order to prevent disability and guarantee quality of life.

Keywords: Biologic drugs; Inflammatory bowel disease; Ocular extraintestinal manifestation; Questionnaire.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Vavricka SR, Schoepfer A, Scharl M, Lakatos PL, Navarini A, Rogler G (2015) Extraintestinal manifestations of inflammatory bowel disease. Inflamm Bowel Dis 21(8):1982–1992 - DOI
    1. Danese S, Semeraro S, Papa A, Roberto I, Scaldaferri F, Fedeli G et al (2005) Extraintestinal manifestations in inflammatory bowel disease. World J Gastroenterol 11(46):7227–7236 - DOI
    1. Vavricka SR, Brun L, Ballabeni P, Pittet V, Prinz Vavricka BM, Zeitz J et al (2011) Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol 106(1):110–119 - DOI
    1. Zippi M, Corrado C, Pica R, Avallone EV, Cassieri C, De Nitto D et al (2014) Extraintestinal manifestations in a large series of Italian inflammatory bowel disease patients. World J Gastroenterol 20(46):17463–17467 - DOI
    1. Troncoso LL, Biancardi AL, De Moraes HV, Zaltman C (2017) Ophthalmic manifestations in patients with inflammatory bowel disease: a review. World J Gastroenterol 23(32):5836–5848 - DOI

LinkOut - more resources